Health & Fitness
Health and Fitness
Health and Fitness
Wed, November 17, 2010
Tue, November 16, 2010
Mon, November 15, 2010
ShangPharma Corp. to Announce Third Quarter 2010 Financial Results on November 23, 2010
SHANGHAI--([ BUSINESS WIRE ])--ShangPharma Corporation (NYSE:SHP) (aShangPharmaa or the aCompanya), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release its unaudited financial results for the third quarter of 2010 on November 23, 2010. Management will host a conference call to discuss the results at 8:00am New York Time on November 23, 2010 (9:00pm Beijing time on November 23, 2010).
Conference Call
Mr. Michael Hui, founder and Chief Executive Officer, Mr. Kevin Chen, Chief Operating Officer and Chief Financial Officer, and Ms. Lan Xie, Vice President of Finance and Operations, will discuss the results and take questions following the prepared remarks.
The dial-in details for the live conference call are as follows:
| - U.S. Toll Free Number: | 1.800.798.2796 | |
| - International dial-in number: | + 1.617.614.6204 | |
| - China Toll Free Number: | 10 800 152 1490 (North) | |
10 800 852 1490 (South) | ||
| - Hong Kong Toll Free Number: | 800 963 844 | |
Passcode: SHP | ||
A live webcast of the conference call will be available on the investor relations section of the Company's website at: [ http://www.shangpharma.com ].
A telephone replay of the call will be available for seven days from November 24, 2010 to November 30, 2010. The dial-in details for the replay are as follows:
| - U.S. Toll Free Number: | 1-888-286-8010 | |
| - International dial-in number: | +1-617-801-6888 | |
Passcode: 59003774 | ||
About ShangPharma Corp.
ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit [ www.shangpharma.com ].
